DMKJ
IOVA icon

David M. Knott Jr’s Iovance Biotherapeutics IOVA Stock Holding History

David M. Knott Jr’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66M Hold
1,600,000
– – 3.52% 8
2026
Q1 		$5.62M Buy
+1,600,000
New +$5.12M 3.34% 8
2022
Q4 		– Sell
-32,614
Closed -$312K – 177
2022
Q3 		$312K Hold
32,614
– – 0.13% 81
2022
Q2 		$360K Buy
32,614
+2,000
+7% +$26.2K 0.15% 73
2022
Q1 		$510K Buy
30,614
+10,594
+53% +$164K 0.16% 77
2021
Q4 		$382K Buy
+20,020
New +$441K 0.13% 75

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

David M. Knott Jr's IOVA Position: Q2 2026 in Review

David M. Knott Jr held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 1,600,000 shares worth $6.66M. The position accounts for 3.52% of the portfolio, ranked #8.

David M. Knott Jr first reported a position in IOVA in Q4 2021 and has held it in 6 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • David M. Knott Jr held 1,600,000 shares of Iovance Biotherapeutics worth $6.66M as of Q2 2026.
  • David M. Knott Jr left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up 3.52% of David M. Knott Jr's portfolio in Q2 2026, its #8 holding.
  • David M. Knott Jr first reported a position in Iovance Biotherapeutics in Q4 2021 and has held it in 6 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.